Daniel G. Jennings is a professional freelance writer, longtime blogger, and recovering journalist with nearly 20 years of writing experience. He has written hundreds of articles and blog posts for clients all over the world, many articles on stocks and financial topics for Motley Fool and Seeking Alpha, and other forms of copy for many different websites. Off the web, Jennings has an MBA and a BA in history; he has also worked for newspapers in four states and in the accounting department of an S&P 500 corporation. He is currently the owner and operator of the Car Insurance Samurai, Market Madhouse, and Make Cash from Books blogs.
I managed large box retail stores for 30 years. I then retired from retail, studied for several years and opened a financial services firm. I was a registered representative for ten years and recently sold my financial services business. Core holdings: EPD, MMP, APTS, BIP, HASI, BX, COR, CVS, DLR, CELG, AMGN, HTGC, JNJ, LMT, MAIN, MHLD, NEWT, NRZ, OHI, RTN, UNP, WPZ, OAK, SIR, SXL, SRLP, TEP, UTX, WPC, MPW, and BIF. As a former Registered Rep, I now own zero mutual funds after seeing how they were destroyed in 2008.
Phil is a practicing Registered Pharmacist who has over 30 years of experience in all aspects of the Pharmaceutical Industry with a core expertise in Dermatology products including those focused in Aesthetic Medicine. Phil started his career in Sales with Eli Lilly and Co. Phil went on to hold Executive Sales, Marketing and Administrative positions at Glaxo Inc. (now GSK) and Fujisawa (now Astellas). Phil first became involved in Dermatology/Aesthetic Medicine while V.P. General Manager North America at ICN Pharmaceuticals (now Valeant) where he managed the Dermatology Portfolio including the glycolic acid based line Glyderm. While at ICN, Phil led the licensing, branding and launch effort of Kinerase®, the most successful single entity cosmetic based line in the U.S. at the time. At ICN Phil also led the re-introduction of Efudex® after its acquisition from Roche and took sales from $14M to $60M in three years. Phil went on to be President and CEO of Obagi Medical Products (OMPI) where he doubled sales in 2 years and was responsible for adding the Vitamin C and tretinoin based products to the Obagi portfolio, as well as leading major expansions in to Japan and Western Europe. He then went on to be President and CEO of Randall International, then the premier provider of custom amenity and Spa products in the U.S. Phil maintains his own consulting business (Rose and Company) specializing in any aspect of the commercialization of prescription, OTC and cosmetic based products, with a focus on Dermatology Products.
As a consultant, Phil led the commercialization planning effort in the U.S. for Peplin Inc. with their novel ingenol mebutate compound in development for Rx treatment of Actinic Keratosis. Peplin was acquired by LEO. The product was approved by the FDA in 12/2011 and is marketed by LEO Pharmaceuticals as Picato®. www.picato.com
Phil is co-founder, Chief Marketing Officer and a Board Member of Peninsula Skincare Labs, Inc. Peninsula was founded in March 2011. Peninsula markets lines of Cosmetic and OTC skincare products for Skin Health/Anti-Ageing, Acne Vulgaris and Acne Rosacea through a novel distribution channel known as PAS (Pharmacist Assisted Sale). Phil successfully led the test marketing of the model and products in South Florida in 2011/2012 and is leading the effort for a National roll-out. www.nurigene.com
Phil is engaged in a consulting role with Pomega, Inc. for the commercial development and launch the PomegaMd and Pomega5 (novel Omega 5 Fatty Acid based products) line of products in to the Physician Dispensed and Prestige/Spa markets respectively. www.pomega5.com
Phil lives with his wife Beth in Fort Mitchell, KY. (Cincinnati, OH.)
Contact: email: firstname.lastname@example.org phone: 859-640-7003